Scottish CMO letter
Continue Reading →Tamoxifen to prevent breast cancer – Inside Health 3/7/18
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)09962-2/fulltext?code=lancet-site .https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/making-decisions-using-nice-guidelines#professional-guidelines https://www.nice.org.uk/guidance/cg164 https://www.nice.org.uk/guidance/cg164/chapter/recommendations#breast-cancer-risk-category
Continue Reading →RCGP council 23/6/18
notes from council please note – there is no point saying something twice, so if other people make the same comment and it’s accepted, it just wastes time to repeat it . This is what I said today Sponsorship review I want the RCGP to stop all sponsorship of the conference and educational modules – […]
Continue Reading →Bowel cancer screening – Inside Health 27/3/18
UK National Screening Committee FOBT versus FIT screening tests and here and here Cochrane review Scottish programme and bowelscope pilot Atkins Lancet paper
Continue Reading →Inside Health 20/3/18 fish oils/adaptive trials
Fish oils: http://www.bbc.co.uk/science/humanbody/mind/articles/intelligenceandmemory/omega_three.shtml http://news.bbc.co.uk/1/hi/england/6991528.stm Fish oil makes children smarter, study claims https://www.telegraph.co.uk/news/health/3083228/Fish-oil-makes-children-smarter-study-claims.html two studies in UK DOLAB 1 and 2 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0043909 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192909 https://theconversation.com/half-of-biomedical-research-studies-dont-stand-up-to-scrutiny-and-what-we-need-to-do-about-that-45149 Click to access 56314e40aac61.pdf adaptive trials: review https://academic.oup.com/jnci/article-abstract/109/6/djx013/3074379?redirectedFrom=fulltext https://academic.oup.com/jnci/article-abstract/109/6/djx013/3074379?redirectedFrom=fulltext https://clinicaltrials.gov/ct2/show/NCT01042379 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706669/ https://www.ncbi.nlm.nih.gov/pubmed/20595245/ https://www.ncbi.nlm.nih.gov/pubmed/25475878
Continue Reading →Inside Health 13/3/18 – antidepressants and evidence
This whole area is confusing, understudied, and messy. I attach some of the references I used for this area. Never was the term ‘better research is needed’ more fitting…. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140701/ https://www.karger.com/Article/FullText/370338 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)72262-5/fulltext https://pdfs.semanticscholar.org/7498/9759b62841d088b4b0afc45564aa48e03af7.pdf?_ga=2.238076672.1267186742.1520784025-1252960857.1520784025 .https://nordic.cochrane.org/sites/nordic.cochrane.org/files/public/uploads/theses/Nielsen%20PhD.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130/ http://www.psychiatrist.com/jcp/article/Pages/2005/v66n10/v66n1015.aspx https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130/
Continue Reading →antidepressants and effectiveness – Inside Health 27/2/18
new Lancet paper other studies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172306/#c18 that view has been challenged https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592645/ the authors retrieved unpublished information for 274 (52%) of the trials included in the meta-analysis. still huge uncertainties lots of unpublished data – known publication bias http://www.nejm.org/doi/full/10.1056/NEJMsa065779 eg a study 10 years ago NEJM – found trials done but not published 94% of […]
Continue Reading →Notes from RCGP council 23/2/18
This is a note of what I said. Of course there are many other things I could have said – but there is little point in doing so if someone else has just made the point – it wastes time. Minutes from last time: Babylon – ‘while undoubtedly a quick convenient way ‘ for some […]
Continue Reading →Inside Health 20/1/18
cannabis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307971/ https://www.nature.com/articles/nrn3530 Our work on cannabis has been delayed because it turned out that cannabis placebo is considered a Schedule 1 drug in the UK. This meant that placebo had to be added to our licence and that import and export licences were then required for obtaining it from overseas suppliers. As these licences […]
Continue Reading →Inside Health- Radio 4 references 30/1/18
Iron: it’s all very interesting… there is a very nice series of GP studies just waiting to be done that cover side effects, rise in Hb, and patient preferences… eg 2005 study 90 older americans in hospital and with IDA l http://www.amjmed.com/article/S0002-9343(05)00210-X/fulltext https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582401/ http://www.who.int/elena/titles/guidance_summaries/iron_women/en/ http://www.sciencedirect.com/science/article/pii/S2352302617301825#ceabs50 http://www.bloodjournal.org/content/126/17/1981.long – aspirin dose and stroke https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/485050
Continue Reading →